Showing: 1 - 7 of 7 RESULTS

Dentist Fortitude Valley, Precision Dental, Offers General and Cosmetic Dentistry Solutions in a Caring and Friendly Environment in QLD – Press Release

Dentist Fortitude Valley, Precision Dental, Offers General and Cosmetic Dentistry Solutions in a Caring and Friendly Environment in QLD

Fortitude Valley, QLD – Not every dentist is the same. There are those that will only be concerned about providing treatment while there are others that will go above and beyond in ensuring that patients are feeling comfortable. Precision Dental is a modern dental practice that is based at the heart of Brisbane servicing Fortitude Valley and is committed to high-quality dental care. The practice provides both general and cosmetic dental treatment for the whole family.

“Our ultra-modern practice is conveniently located in HQ Towers which offer free onsite parking for the duration of treatment. Emergency appointments are available throughout the day and Saturday appointments can be arranged. We are equipped with the latest generation of equipment and pride ourselves in providing thorough dental treatment that is tailored to individual needs and goals.” Said Dr Billy Choi, the spokesperson for the clinic, regarding their unrivalled services.

The dental practice was founded on three key principles including honesty, patient comfort, and quality. Every member of the staff will ensure that patients are comfortable right from the moment they walk in their office. The clinic uses the latest generation of quiet equipment to ensure that dental visits are enjoyable. Some of the tools that can be found in the treatment room to make patients relax include:


Parents can rest easy knowing that the clinic offers children’s dental emergency treatments. Children have high energy and are always going to be susceptible to dental emergencies. The dentists have knowledge in dealing with such unexpected events and will ensure that children are not experiencing discomfort a minute longer. The practice applies advanced skills in dentistry and state-of-the-art equipment to overcome dental emergencies.

The clinic also aims at being the leading cosmetic dentistry treatment provider in Fortitude Valley, one smile at a time. The treatment options are tailored to meet the individual needs of the patient. A good dentist Fortitude Valley is one that will start by assessing the individual needs of the patient before coming up with a course of action and this is exactly what you get when you reach out to Precision Dental. Getting a smile makeover will help in maintaining a youthful appearance and also boosts the self-confidence of a person. Patients can enjoy all of these benefits by booking a dental appointment with Precision Dental at their own convenient time.

The clinic also believes in providing education to patients because good dental care requires a holistic approach. The clinic believes that a dentist should be a partner when it comes to the wellbeing of the teeth, gums, and mouth. Precision Dental provides patients with both basic and advanced information so that they’re establishing a consistent and reliable oral care routine. It is also easy for patients to book an appointment when they visit their website.

Precision Dental is located at S13, HQ South Tower, 520 Wickham St, Fortitude Valley, QLD 4006. For enquiries regarding the top-rated dentist Fortitude Valley and the services offered, contact their team by calling (07) 3852 1160

DNA Dental Comprises the Best Dentist in Dallas, TX, Offering Cosmetic, General, and Restorative Dental Care and Treatment Solutions – Press Release

DNA Dental Comprises the Best Dentist in Dallas, TX, Offering Cosmetic, General, and Restorative Dental Care and Treatment Solutions

Dallas, TX – Dallas, TX residents who are in search of 5-star and premium dental care and treatment solutions can now rest assured that the team at DNA Dental brings this quality of services to them at affordable rates. The dental clinic in Dallas, TX boasts a team of experienced and professional dental specialists who are constantly improving on their dental practice to ensure that each patient is given the attention and care they deserve.

Focused on improving the oral health and wellness of the members of the community, DNA Dental has proudly expanded on its dentistry practice to offer a wide range of dental solutions, including the very best children’s dentistry solutions in the area. Children who come into the dental clinic will have access to the very best and experienced pediatric dentists who are committed to creating the best dental care and treatment experiences using the latest dental tools, technology, and procedures while also aiming for a pain-free dental care and treatment experience.

The entire team of Dentist at DNA Dental also focus on helping children to form the right dental foundations for their oral health and wellness needs. Added to this, the dental clinic boasts of the best Cosmetic Dentist in the Dallas, TX area. The professional cosmetic dentist offers a range of popular cosmetic dental services that are designed to help patients to reach the goal they have for a bright and beautiful smile.

Describing the dental solutions offered at the clinic, Dr. Darya Timin, the spokesperson for DNA Dental said, “Here at DNA Dental, we are committed to providing gentle care to every member of your family. We understand that you may feel nervous about your dental visits, and we are here to help you feel relaxed and comfortable. Our dentists and team are proud to provide quality, gentle dentistry solutions. We invite you to contact our friendly team today to learn more about our comprehensive services and to schedule your next appointment with one of our experienced dentists. Take your next step toward a healthy smile today!”

Serving patients in Dallas, TX, and the surrounding areas, DNA Dental also offers comprehensive restorative dentistry solutions including dental bridges, dental crowns, dental implants, dentures, and dental fillings.

Patients who visit the clinic will have access to the latest dental technologies, as well as a cutting-edge approach to dental care and treatment.

DNA Dental is located at 6162 E Mockingbird Ln Ste 205, Dallas, TX 75214, US. For top-quality dental care and treatment solutions, contact their team by calling +1 214-817-3113 to schedule an appointment. For additional information regarding their services, send an email to info@dnadentaldallas.com or visit the dental clinic’s website.

Media Contact
Company Name: DNA Dental
Contact Person: Dr. Darya Timin
Email: Send Email
Phone: +1 214-817-3113
Address:6162 E Mockingbird Ln Ste 205
City: Dallas
State: TX
Country: United States
Website: https://dnadentaldallas.com/

// Load the SDK Asynchronously (function(d){ var js, id …

AccuRisk Solutions Welcomes David Przesiek as New CEO to Tactical Risk Solutions

AccuRisk Solutions LLC, a nationally recognized leader in innovative insurance solutions, continues to strategically invest in the company’s growth with the addition of David Przesiek as CEO of Tactical Risk Solutions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008006010/en/

Dave Przesiek, President of Tactical Risk Solutions (Photo: Business Wire)

David Przesiek is a 25-year veteran of the health insurance industry. Formerly a Senior Vice President and Chief Sales Officer for Fallon Community Health, Przesiek was responsible for all product lines including commercial sales and government programs as well as market research, business and product development and UltraBenefits, Inc., and Group Insurance Service Center, Inc. (GISC), Fallon’s third-party administrators. In his role at Fallon, he oversaw the introduction of limited networks, a transparency tool called SmartShopper, a comprehensive wellness program called the Healthy Health Plan and helped kicked off a strategic initiative aimed at improving the customer experience for Fallon Health.

“We are thrilled that David is on the AccuRisk team. David will be responsible for developing and executing the strategy of Tactical Risk Solutions as we look to launch products to meet the benefit needs of employers across the country,” said AccuRisk CEO Daniel Boisvert. “His experience and reputation will help us elevate Tactical Risk Solutions to a new level of success, and we are looking forward to see David unleash the potential of the captive model and create a profitable and sustainable company.”

“I’m thrilled to join AccuRisk during this exciting period of company growth. AccuRisk is known for their innovative solutions and I’m looking forward to being part of such an established market leader,” said Przesiek. “I’m passionate about driving innovation in health care for employers and brokers and improving the member’s experience. With AccuRisk, this can actually be accomplished.”

About AccuRisk Solutions LLC

AccuRisk Solutions LLC is a Chicago-based Managing General Underwriter focused on providing its producers with innovative insurance products and outstanding customer service. The AccuRisk executive management team is composed of proven leaders within the industry who are driven to provide better results for clients. AccuRisk partners with leading insurance carriers and healthcare visionaries to provide a comprehensive array of healthcare and employee benefit solutions. Their objective is to assist producers in providing their employer clients with unique and cost-effective solutions. Visit www.accurisksolutions.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201008006010/en/

Contacts

David Przesiek
DPrzesiek@accurisksolutions.com

Source Article

How Can Pharma Companies Simplify the Five-Phase Drug Development Process? Infiniti’s Experts Highlight the Need for Product Research Solutions

The increasing competition of the pharmaceutical industry has encouraged companies to invest in innovation and drug development. However, the drug development process is challenging, and without appropriate guidance, developers can face various roadblocks. What is the solution? Infiniti’s product research solutions enable companies to identify, evaluate, and strategize for potential roadblocks through the process. Additionally, our product research experts provide drug developers with crucial insights regarding target customers, regulatory requirements, and competitors’ strategies through the process. This further provides companies with a strategic advantage and enables them to successfully develop and launch a new drug and monitor their success efficiently. To leverage Infiniti’s product research solutions for comprehensive insights regarding the drug development process and an effective strategy, request a free proposal.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005908/en/

Five Phases of the Drug Development Process (Graphic: Business Wire)

With constant technological and pharmaceutical advancements, the pharmaceutical industry is continually becoming more competitive and challenging. Pharmaceutical companies need to focus on innovation and stay ahead of the curve to acquire and maintain market share successfully. Therefore, many pharma companies and researchers have shifted focus on drug development. The drug development process is long drawn and includes multiple phases. It is a five-phase process in the United States and acquiring regulatory approval from the Food and Drug Administration (FDA) is extremely challenging. Therefore, Infiniti’s experts decided to simplify the five-phase drug development process and discuss the value of product research solutions during every stage of the process in their recent article.

Gain comprehensive insights into the five phases of the drug development process and the value of product research solutions by reading the complete article here.

“Although the drug development process becomes easier with more available resources, workforce, and a better understanding of the regulatory requirements, many major pharma companies may still struggle to complete the process without experts’ guidance,” says a pharmaceutical industry expert at Infiniti Research.

Infiniti’s product research experts discussed the following five phases of the drug development process:

  • Discovery and development of a particular compound that elicits a desirable effect on the druggable target for any disease and developing a drug candidate

  • Preclinical research involves testing of the drug candidate on an animal species with similar genetic makeup as humans and gaining an understanding of the dosage and toxicity levels

  • Designing a clinical trial, developing a protocol, and submitting an IND application is part of the third phase of the drug development process

  • The relevant information procured from the preclinical and clinical research is submitted to the FDA for review, and it is either approved, delayed, or referred to an advisory committee for further review

  • The fifth phase involves surveillance of the drug after it has been approved, manufactured, and marketed. This aims to analyze the long-term efficacy and safety of the drug and involves various inspections by FDA representatives

To learn how Infiniti Research helps pharma companies strategize for each phase efficiently, and overcome potential bottlenecks with product research

Nicole Chappelle Joins Ametros as Vice President of Settlement Solutions

Ametros welcomes Nicole Chappelle as Vice President of Settlement Solutions, leading the professional administrator’s strategy for comprehensive and innovative settlement initiatives.

“Nicole’s strong background in workers’ compensation, working with insurers, third-party administrators and other stakeholders in the settlement process, makes her well qualified to support our clients and partners and guide injured individuals through the settlement process,” said Mark Doherty, Executive Vice President of Sales.

Chappelle brings 28 years of experience to this newly created position, most recently as Claims Auditor Claims Central Audit for AmTrust Financial Services. She is a former Assistant Vice President for Gallagher Bassett and has served in litigation management, hearing representation, and claims supervision for several insurance companies. She started her career with Travelers Insurance.

Chappelle earned her Bachelor of Arts degree from the University of California in Santa Barbara and her expertise spans workers’ compensation statutes, regulations, and case law.

“Nicole brings a lot of value, especially right now as the Centers for Medicare and Medicaid Services (CMS) is sharing its concerns with self-administered Medicare Set Asides and as various stakeholders, including payers and attorneys representing injured workers leverage professional administration more in the settlement process,” Doherty added.

In addition to administering MSAs, Ametros helps members navigate the healthcare system and reduce their medical and pharmaceutical costs. Members can receive discounts on office visits, durable medical equipment, home health services, and pharmacy and other healthcare services related to their injuries.

ABOUT AMETROS

Ametros is the industry leader in post-settlement medical administration and a trusted partner for thousands of members receiving funds from workers’ compensation and liability settlements. Founded in 2010, Ametros provides post-settlement medical management services with significant medical and pharmacy discounts along with automated payment technology and Medicare reporting tools. Headquartered just north of Boston in Wilmington, Massachusetts, Ametros may be reached at 877.275.7415 or via www.ametros.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201008005134/en/

Contacts

Ametros
Melissa Wright, 978-381-4329
mwright@ametros.com

Source Article

CorroHealth Emerges as a Leader in Healthcare Reimbursement Solutions, Following Merger of Four Industry Players

Four healthcare services and technology organizations have launched under a combined brand—CorroHealth. TrustHCS, Visionary RCM, T-System and RevCycle+ joined forces to provide a greater breadth of reimbursement cycle, risk adjustment and quality solutions to health systems and payers. Global investment firm The Carlyle Group (NASDAQ: CG) owns a majority stake in CorroHealth, with Cannae Holdings, Inc. (NYSE: CNNE), Sanaka Group, and affiliates of TripleTree Holdings also serving as investors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005234/en/

Patrick Leonard serves as CEO of CorroHealth. (Image: CorroHealth)

CorroHealth—driven by helping clients navigate regulatory and compliance complexities to ease physician burdens and improve financial outcomes—emerges at a time when financial health is particularly important for health systems and payers.

“We knew health systems and plans would have a growing need for our solutions, so we worked hard and found a way to bring all 4,000 employees together as one company—united by our core,” said CorroHealth CEO Patrick Leonard. “At CorroHealth, we will drive results for our clients with our scalable solutions, clinical expertise, and our ability to manage across the continuum of complexity and value.”

CorroHealth combines the industry-leading domestic middle revenue cycle group of TrustHCS, with the full-service global delivery model of Visionary RCM, the emergency documentation technology solutions of T-System, and the advanced coding solutions of RevCycle+.

“Our new and unified brand name speaks to our mission to advance health by connecting people to the right solutions at the right time,” added Leonard. “We are proud of our fully integrated team and excited for the growth journey ahead.”

“We see the highly complementary nature of CorroHealth’s solutions as uniquely able to add value for health system and health plan customers,” said Joe Bress, a Principal specializing in healthcare at The Carlyle Group. “We’re excited to partner with Pat and the company’s leading management team to help build the CorroHealth platform.”

“We believe CorroHealth is well positioned for organic and inorganic growth opportunities,” added fellow Carlyle Principal James Shillito. “Carlyle and the entire investor group look forward to supporting this growth going forward.”

The four legacy company names will remain through the end of 2020 with a final move to the CorroHealth name across all companies beginning Jan. 1, 2021.

Equity capital for the investment came from the Carlyle Equity Opportunity Fund II that makes majority and strategic minority investments primarily in the U.S. in targeted industries, including healthcare.

About CorroHealth

Our core purpose is to help you exceed your financial health goals. Across the reimbursement cycle, our scalable programs and clinical expertise help solve programmatic needs. Enabling our skilled domestic and global teams with leading technology allows analytics to guide our solutions and keeps us accountable to your goals. For both health systems and plans, we navigate regulatory and compliance complexities, ease physician burdens and improve financial outcomes. We consistently deliver the right solutions at the right time.

For additional information about CorroHealth, please visit www.CorroHealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200930005234/en/

Contacts

Sara Payne,

Organoids Market: Growing Concerns about Systematic Treatment Solutions for Personalised Medicine to Drive the Market Growth

Global Organoids Market: An Overview

The global organoids Market is a fragmented landscape with several new players driving intense competition and rising investment in innovation. Recent advancements in Big Data, and technologies like 3D printing have opened up new skies of growth for innovation.

Organoids is a simplified and compact version of organs which depicts micro-anatomy realistically. These are usually made up of stem cells, tissues, or pluripotent stem cells. These can organize themselves in three-dimensions, which is key to its realistic representation of organism.

In 2013, the scientific community named the development in organoids as one of the biggest scientific achievement in recent times. This is not surprising as understanding real-movements of organs allows scientists to study various abnormal as well as healthy behaviour in cells, and test new drugs to bring forth solutions to challenges such as Alzheimer’s disease which are yet to be completely understood. Technologies like Big Data promise to a rapid progress in understanding cells, while 3D printing promises more realistic, and more diversification in materials used for research.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73363

Global Organoids Market: Trends and Opportunities

A new study published in the National Institutes of Health Journal shows that La Crosse Virus or LACV can cause inflammation of the brain in children. The study also shows that at different stages of development cycle, the cells affect children differently. The study relied on the use of organoids for the understanding the primary function of brain cells in the nervous cell system. The study and rising concerns about neurons causal relationship with LACV promise new research opportunities for end-players.

Rise in chronic diseases including most forms of cancer, and new little understood major illnesses like Alzheimer’s have rung many alarm bells in the healthcare sector. Additionally, the cost of treatment for many of these diseases remains extremely high and out of reach for many patients.

The rising population of elderly, increased investment in research for chronic illnesses, and growing burden on healthcare system are expected to drive more capital towards research and innovation. Moreover, advancements in organoids replacing conventional 2D cells with a 3D model promises new growth opportunities for researchers in return. Growing concerns about systematic treatment solutions for personalised medicine will also drive new opportunities for growth in the organoids market.

Request for Analysis of COVID-19 Impact on Organoids Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73363

Global Organoids Market: Regional Outlook

The global organoids market report covers all regions including North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Among these, the North American region is likely to post highest revenues, thanks to increasing technological adoption of big data, and faster streamlining process by the FDA.  The new drive to innovation in the industry is a major trend in the region as old patents expire, and new opportunities due to a bigger push by the regulatory environment drives growth in the region. The global organoids market is also expected to register robust growth in Asia Pacific, as increasing private investments for